Cargando…
AKT1 polymorphisms are associated with risk for metabolic syndrome
Converging lines of evidence suggest that AKT1 is a major mediator of the responses to insulin, insulin-like growth factor 1 (IGF1), and glucose. AKT1 also plays a key role in the regulation of both muscle cell hypertrophy and atrophy. We hypothesized that AKT1 variants may play a role in the endoph...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3020305/ https://www.ncbi.nlm.nih.gov/pubmed/21061022 http://dx.doi.org/10.1007/s00439-010-0910-8 |
_version_ | 1782196285361618944 |
---|---|
author | Devaney, Joseph M. Gordish-Dressman, Heather Harmon, Brennan T. Bradbury, Margaret K. Devaney, Stephanie A. Harris, Tamara B. Thompson, Paul D. Clarkson, Priscilla M. Price, Thomas B. Angelopoulos, Theodore J. Gordon, Paul M. Moyna, Niall M. Pescatello, Linda S. Visich, Paul S. Zoeller, Robert F. Seip, Richard L. Seo, Jinwook Kim, Bo Hyoung Tosi, Laura L. Garcia, Melissa Li, Rongling Zmuda, Joseph M. Delmonico, Matthew J. Lindsay, Robert S. Howard, Barbara V. Kraus, William E. Hoffman, Eric P. |
author_facet | Devaney, Joseph M. Gordish-Dressman, Heather Harmon, Brennan T. Bradbury, Margaret K. Devaney, Stephanie A. Harris, Tamara B. Thompson, Paul D. Clarkson, Priscilla M. Price, Thomas B. Angelopoulos, Theodore J. Gordon, Paul M. Moyna, Niall M. Pescatello, Linda S. Visich, Paul S. Zoeller, Robert F. Seip, Richard L. Seo, Jinwook Kim, Bo Hyoung Tosi, Laura L. Garcia, Melissa Li, Rongling Zmuda, Joseph M. Delmonico, Matthew J. Lindsay, Robert S. Howard, Barbara V. Kraus, William E. Hoffman, Eric P. |
author_sort | Devaney, Joseph M. |
collection | PubMed |
description | Converging lines of evidence suggest that AKT1 is a major mediator of the responses to insulin, insulin-like growth factor 1 (IGF1), and glucose. AKT1 also plays a key role in the regulation of both muscle cell hypertrophy and atrophy. We hypothesized that AKT1 variants may play a role in the endophenotypes that make up metabolic syndrome. We studied a 12-kb region including the first exon of the AKT1 gene for association with metabolic syndrome-related phenotypes in four study populations [FAMUSS cohort (n = 574; age 23.7 ± 5.7 years), Strong Heart Study (SHS) (n = 2,134; age 55.5 ± 7.9 years), Dynamics of Health, Aging and Body Composition (Health ABC) (n = 3,075; age 73.6 ± 2.9 years), and Studies of a Targeted Risk Reduction Intervention through Defined Exercise (STRRIDE) (n = 175; age 40–65 years)]. We identified a three SNP haplotype that we call H1, which represents the ancestral alleles at the three loci and H2, which represents the derived alleles at the three loci. In young adult European Americans (FAMUSS), H1 was associated with higher fasting glucose levels in females. In middle age Native Americans (SHS), H1 carriers showed higher fasting insulin and HOMA in males, and higher BMI in females. In older African-American and European American subjects (Health ABC) H1 carriers showed a higher incidence of metabolic syndrome. Homozygotes for the H1 haplotype showed about twice the risk of metabolic syndrome in both males and females (p < 0.001). In middle-aged European Americans with insulin resistance (STRRIDE) studied by intravenous glucose tolerance test (IVGTT), H1 carriers showed increased insulin resistance due to the Sg component (p = 0.021). The 12-kb haplotype is a risk factor for metabolic syndrome and insulin resistance that needs to be explored in further populations. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00439-010-0910-8) contains supplementary material, which is available to authorized users. |
format | Text |
id | pubmed-3020305 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Springer-Verlag |
record_format | MEDLINE/PubMed |
spelling | pubmed-30203052011-02-22 AKT1 polymorphisms are associated with risk for metabolic syndrome Devaney, Joseph M. Gordish-Dressman, Heather Harmon, Brennan T. Bradbury, Margaret K. Devaney, Stephanie A. Harris, Tamara B. Thompson, Paul D. Clarkson, Priscilla M. Price, Thomas B. Angelopoulos, Theodore J. Gordon, Paul M. Moyna, Niall M. Pescatello, Linda S. Visich, Paul S. Zoeller, Robert F. Seip, Richard L. Seo, Jinwook Kim, Bo Hyoung Tosi, Laura L. Garcia, Melissa Li, Rongling Zmuda, Joseph M. Delmonico, Matthew J. Lindsay, Robert S. Howard, Barbara V. Kraus, William E. Hoffman, Eric P. Hum Genet Original Investigation Converging lines of evidence suggest that AKT1 is a major mediator of the responses to insulin, insulin-like growth factor 1 (IGF1), and glucose. AKT1 also plays a key role in the regulation of both muscle cell hypertrophy and atrophy. We hypothesized that AKT1 variants may play a role in the endophenotypes that make up metabolic syndrome. We studied a 12-kb region including the first exon of the AKT1 gene for association with metabolic syndrome-related phenotypes in four study populations [FAMUSS cohort (n = 574; age 23.7 ± 5.7 years), Strong Heart Study (SHS) (n = 2,134; age 55.5 ± 7.9 years), Dynamics of Health, Aging and Body Composition (Health ABC) (n = 3,075; age 73.6 ± 2.9 years), and Studies of a Targeted Risk Reduction Intervention through Defined Exercise (STRRIDE) (n = 175; age 40–65 years)]. We identified a three SNP haplotype that we call H1, which represents the ancestral alleles at the three loci and H2, which represents the derived alleles at the three loci. In young adult European Americans (FAMUSS), H1 was associated with higher fasting glucose levels in females. In middle age Native Americans (SHS), H1 carriers showed higher fasting insulin and HOMA in males, and higher BMI in females. In older African-American and European American subjects (Health ABC) H1 carriers showed a higher incidence of metabolic syndrome. Homozygotes for the H1 haplotype showed about twice the risk of metabolic syndrome in both males and females (p < 0.001). In middle-aged European Americans with insulin resistance (STRRIDE) studied by intravenous glucose tolerance test (IVGTT), H1 carriers showed increased insulin resistance due to the Sg component (p = 0.021). The 12-kb haplotype is a risk factor for metabolic syndrome and insulin resistance that needs to be explored in further populations. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00439-010-0910-8) contains supplementary material, which is available to authorized users. Springer-Verlag 2010-11-09 2011 /pmc/articles/PMC3020305/ /pubmed/21061022 http://dx.doi.org/10.1007/s00439-010-0910-8 Text en © The Author(s) 2010 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
spellingShingle | Original Investigation Devaney, Joseph M. Gordish-Dressman, Heather Harmon, Brennan T. Bradbury, Margaret K. Devaney, Stephanie A. Harris, Tamara B. Thompson, Paul D. Clarkson, Priscilla M. Price, Thomas B. Angelopoulos, Theodore J. Gordon, Paul M. Moyna, Niall M. Pescatello, Linda S. Visich, Paul S. Zoeller, Robert F. Seip, Richard L. Seo, Jinwook Kim, Bo Hyoung Tosi, Laura L. Garcia, Melissa Li, Rongling Zmuda, Joseph M. Delmonico, Matthew J. Lindsay, Robert S. Howard, Barbara V. Kraus, William E. Hoffman, Eric P. AKT1 polymorphisms are associated with risk for metabolic syndrome |
title | AKT1 polymorphisms are associated with risk for metabolic syndrome |
title_full | AKT1 polymorphisms are associated with risk for metabolic syndrome |
title_fullStr | AKT1 polymorphisms are associated with risk for metabolic syndrome |
title_full_unstemmed | AKT1 polymorphisms are associated with risk for metabolic syndrome |
title_short | AKT1 polymorphisms are associated with risk for metabolic syndrome |
title_sort | akt1 polymorphisms are associated with risk for metabolic syndrome |
topic | Original Investigation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3020305/ https://www.ncbi.nlm.nih.gov/pubmed/21061022 http://dx.doi.org/10.1007/s00439-010-0910-8 |
work_keys_str_mv | AT devaneyjosephm akt1polymorphismsareassociatedwithriskformetabolicsyndrome AT gordishdressmanheather akt1polymorphismsareassociatedwithriskformetabolicsyndrome AT harmonbrennant akt1polymorphismsareassociatedwithriskformetabolicsyndrome AT bradburymargaretk akt1polymorphismsareassociatedwithriskformetabolicsyndrome AT devaneystephaniea akt1polymorphismsareassociatedwithriskformetabolicsyndrome AT harristamarab akt1polymorphismsareassociatedwithriskformetabolicsyndrome AT thompsonpauld akt1polymorphismsareassociatedwithriskformetabolicsyndrome AT clarksonpriscillam akt1polymorphismsareassociatedwithriskformetabolicsyndrome AT pricethomasb akt1polymorphismsareassociatedwithriskformetabolicsyndrome AT angelopoulostheodorej akt1polymorphismsareassociatedwithriskformetabolicsyndrome AT gordonpaulm akt1polymorphismsareassociatedwithriskformetabolicsyndrome AT moynaniallm akt1polymorphismsareassociatedwithriskformetabolicsyndrome AT pescatellolindas akt1polymorphismsareassociatedwithriskformetabolicsyndrome AT visichpauls akt1polymorphismsareassociatedwithriskformetabolicsyndrome AT zoellerrobertf akt1polymorphismsareassociatedwithriskformetabolicsyndrome AT seiprichardl akt1polymorphismsareassociatedwithriskformetabolicsyndrome AT seojinwook akt1polymorphismsareassociatedwithriskformetabolicsyndrome AT kimbohyoung akt1polymorphismsareassociatedwithriskformetabolicsyndrome AT tosilaural akt1polymorphismsareassociatedwithriskformetabolicsyndrome AT garciamelissa akt1polymorphismsareassociatedwithriskformetabolicsyndrome AT lirongling akt1polymorphismsareassociatedwithriskformetabolicsyndrome AT zmudajosephm akt1polymorphismsareassociatedwithriskformetabolicsyndrome AT delmonicomatthewj akt1polymorphismsareassociatedwithriskformetabolicsyndrome AT lindsayroberts akt1polymorphismsareassociatedwithriskformetabolicsyndrome AT howardbarbarav akt1polymorphismsareassociatedwithriskformetabolicsyndrome AT krauswilliame akt1polymorphismsareassociatedwithriskformetabolicsyndrome AT hoffmanericp akt1polymorphismsareassociatedwithriskformetabolicsyndrome |